'Macitentan' presentation slideshows

Seraphin : results from a landmark study

Seraphin : results from a landmark study. SERAPHIN: Creating a robust morbidity and/or mortality primary endpoint. Inclusion of a 3 rd criterion for PAH worsening (need for new treatment(s) for PAH). Complexity & robustness. Measurable definition of PAH worsening (6-MWD & FC).

895 views • 19 slides

Seraphin : results from a landmark study

Seraphin : results from a landmark study. SERAPHIN: Creating a robust morbidity and/or mortality primary endpoint. Inclusion of a 3 rd criterion for PAH worsening (need for new treatment(s) for PAH). Complexity & robustness. Measurable definition of PAH worsening (6-MWD & FC).

273 views • 19 slides

233 views • 15 slides